,2 However, various types of cancer constitutively express PD-L1, either as a result of structural alterations in the regulatory 3′ region of the PD-L1 gene,9 or through activation of the STAT3 and AKT pathways, which are common features of cancer.10 The gene discussed is STAT3; the disease is cancer.